Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kymera Therapeutics, Inc.

25.97
+0.95003.80%
Post-market: 25.970.00000.00%16:35 EDT
Volume:468.79K
Turnover:12.00M
Market Cap:1.69B
PE:-8.71
High:26.03
Open:25.00
Low:24.72
Close:25.02
Loading ...
May 04, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 10, 2023

Major Issues Report

8-K - Current report
Feb 27, 2023

Major Issues Report

8-K - Current report
Feb 23, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 23, 2023

Major Issues Report

8-K - Current report
Feb 23, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 06, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 10, 2023

Major Issues Report

8-K - Current report
Dec 14, 2022

Major Issues Report

8-K - Current report
Dec 14, 2022

Major Issues Report

8-K - Current report
Nov 03, 2022

Major Issues Report

8-K - Current report
Nov 03, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 13, 2022

Major Issues Report

8-K - Current report
Aug 23, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 19, 2022

Major Issues Report

8-K - Current report